Itraconazole

CHEMBL64391 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
705.6 g/mol
LogP
5.7
Phase
4

This broad-spectrum triazole antifungal is used to treat various fungal infections including aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and candidiasis. It works by inhibiting ergosterol synthesis, an essential component of the fungal cell membrane. It has many drug interactions due to its inhibition of liver cytochrome P450 enzymes.

น้ำหนักโมเลกุล

705.6000 g/mol

LogP

5.70

TPSA

101.00 Ų

Lipinski RO5

ไม่ผ่าน

ด้านการรักษา

กลไกการออกฤทธิ์

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O

InChI

InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3

Molecular Formula

C35H38Cl2N8O4

HBD / HBA

- / 9

พันธะที่หมุนได้

11

อะตอมหนัก

49

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

This broad-spectrum triazole antifungal is used to treat various fungal infections including aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and candidiasis. It works by inhibiting ergosterol synthesis, an essential component of the fungal cell membrane. It has many drug interactions due to its inhibition of liver cytochrome P450 enzymes.

Inhibits the fungal cytochrome P450 enzyme lanosterol 14-alpha-demethylase, blocking ergosterol synthesis essential for fungal cell membrane integrity.

Yes, Itraconazole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL64391. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 55283. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.